Prev Close | 12.74 |
Open | 13.33 |
Day Low/High | 11.02 / 13.50 |
52 Wk Low/High | 10.27 / 11.58 |
Volume | 5.67M |
Prev Close | 12.74 |
Open | 13.33 |
Day Low/High | 11.02 / 13.50 |
52 Wk Low/High | 10.27 / 11.58 |
Volume | 5.67M |
Exchange | NYSE |
Shares Outstanding | 37.50B |
Market Cap | 420.75M |
Div & Yield | N.A. (N.A) |
These companies are the hottest thing going.
Combined Heinz-Kraft heads a long second-quarter list.
The CEO of Allergan has created value for shareholders.
Update: Futures positive as quarter closes; J&J sells ortho unit.
Sorry, but I have to be a tad cautious and play the skeptic.
Splitting a company is chronically misunderstood by the marketplace.
Expect more 2014 growth from Alcoa and Devon Energy.
Companies also went shopping on the Presidents Day holiday weekend as Actavis bought Forest Laboratories for $25 billion and Ashland sold its water treatment unit for $1.8 billion. Carl Icahn must be especially happy with the Forest Labs sale as he tried not, once, but twice to get the company to sell itself and still owns a stake in the biotech. It also augurs well for Wall Street advisers who have been waiting for a recovering economy to support an uptick in mergers and acquisitions.
James Molloy, Managing Director at Janney Montgomery Scott explains why Actavis buying Forest Labs is a smart for Actavis and weighs in on speculation over whether or not Forest Labs is likely to receive a better offer.
Consolidation is the key to finding them.
Candy Crush to go public; futures look to extend gains.
Let's run through them.
This will be be a key factor of successful investing next year.
You'd do well to sit up and take notice of them.
Lockheed Martin and Forest Laboratories upgraded at TheStreet Quant Ratings. TheStreet's Brittany Umar details today's ratings changes.
Portfolio Manager David Peltier offers his pre-market outlook.